Peptide Drug

Home > API Products > Peptide Drug
Abaloparatide

Abaloparatide

  • Category Osteroporosis
  • CAS 247062-33-5
  • Specification In-house
  • US DMF N/A
  • CEP / Other DMF N/A
  • GMP certification N/A
  • Inspection N/A
  • StatusDevelopment
  • Major Market USA, EU, Japan